Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
opioid |
| gptkbp:CASNumber |
63902-87-0
|
| gptkbp:drugClass |
opioid
|
| gptkbp:has_stereochemistry |
6-beta
|
| gptkbp:hasInChIKey |
QJQYQKZDHGZBHD-UXBLZVDNSA-N
|
| gptkbp:hasMolecularFormula |
C20H23NO4
|
| gptkbp:hasSMILES |
C=CCN1CCC23C4C1CC5=C2C(=C(C=C5)O)O4CC(C3=O)O
|
| gptkbp:hasUNII |
6Q1K7F1D1E
|
| https://www.w3.org/2000/01/rdf-schema#label |
6-beta-naltrexol
|
| gptkbp:isomerOf |
gptkb:naltrexone
naltrexol |
| gptkbp:IUPACName |
(4R,4aS,7aR,12bS)-3,14-dihydroxy-4,5-epoxy-17-(prop-2-en-1-yl)morphinan-6-one
|
| gptkbp:metabolism |
gptkb:naltrexone
|
| gptkbp:PubChem_CID |
CHEMBL2103847
5484726 |
| gptkbp:bfsParent |
gptkb:naltrexone
|
| gptkbp:bfsLayer |
7
|